Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Heart Journal

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/EHL180PMID 16887854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals : a randomised placebo-controlled trial.

  2008cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

  2006cited by this paper
• C-reactive protein levels and outcomes after statin therapy.

  2005cited by this paper
• Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial.

  2005cited by this paper
• Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).

  2005cited by this paper
• C-reactive protein levels and outcomes after statin therapy.

  2005cited by this paper
• The management and investigation of elderly patients with acute coronary syndromes without ST elevation: an evidence-based approach? Results of the Prospective Registry of Acute Ischaemic Syndromes in the United Kingdom (PRAIS-UK).

  2005influential reference
• Secondary prevention of coronary heart disease in the elderly

  2005cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002influential reference
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age): An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Benefits of Pravastatin on Cardiovascular Events and Mortality in Older Patients with Coronary Heart Disease Are Equal to or Exceed Those Seen in Younger Patients: Results from the LIPID Trial

  2001cited by this paper
• Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction: Data From the National Registry of Myocardial Infarction 3

  2001cited by this paper
• Evidence for age-based rationing in a Swiss university hospital.

  2001cited by this paper
• Effect of Pravastatin on Cardiovascular Events in Older Patients with Myocardial Infarction and Cholesterol Levels in the Average Range: Results of the Cholesterol and Recurrent Events (CARE) Trial

  1998cited by this paper
• Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)

  1997cited by this paper
• Proportional hazards tests and diagnostics based on weighted residuals

  1994cited by this paper
• The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.

  1989cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly

  2025cites this paper
• The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review

  2023cites this paper
• Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications.

  2022cites this paper
• Should statin therapy be used in medication of elderly patients?

  2022cites this paper
• Are Statins Indicated in Senior Citizens? A Review of Statin Therapy in the Elderly.

  2021cites this paper
• Lipid control in geriatric DM patients

  2021cites this paper
• Pharmacological Management of Hyperlipidemia in Older individuals.

  2021cites this paper
• Acute Coronary Syndrome in Octogenerians: Management Perspectives

  2020cites this paper
• The Prevention of Cardiovascular Disease in Older Adults

  2020cites this paper
• Choosing statins: a review to guide clinical practice

  2020cites this paper
• Management of high cholesterol levels in older people

  2019cites this paper
• Acute Coronary Syndromes in the Elderly [version 1; peer review: 3 approved]

  2019cites this paper
• Drug Therapy of Dyslipidemia in the Elderly

  2019cites this paper
• Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

  2019cites this paper
• From the American Heart Association Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults : A

  2018cites this paper
• Appropriateness of statin prescription in the elderly.

  2018cites this paper
• Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study

  2017cites this paper
• Acute Coronary Syndromes in the Elderly

  2017cites this paper
• Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal  70 mg/dl: a real-life cohort in a developing

  2016cites this paper
• Reduction in total recurrent cardiovascular events in acute coronary syndrome patients with low-density lipoprotein cholesterol goal <70 mg/dL: a real-life cohort in a developing country

  2016cites this paper
• Clinical indicators for recurrent cardiovascular events in acute coronary syndrome patients treated with statins under routine practice in Thailand: an observational study

  2015cites this paper
• Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

  2015cites this paper
• Contemporary Trends of Optimal Evidence‐Based Medical Therapy at Discharge for Patients Surviving Acute Myocardial Infarction From the Korea Acute Myocardial Infarction Registry

  2015cites this paper
• Statin Use Following Hospitalization Among Medicare Beneficiaries With a Secondary Discharge Diagnosis of Acute Myocardial Infarction

  2015cites this paper
• Protective Role of Statins in Patients With Acute Coronary Syndrome Aged ≥75 Years With Low LDL-C Who Underwent Percutaneous Coronary Intervention

  2014cites this paper
• Lipid-lowering therapy in patients 75 years and older: clinical priority or superfluous therapy?

  2014cites this paper
• Management and Care of Older Cardiac Patients

  2014cites this paper
• Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.

  2013cites this paper
• Ageing mechanisms and associated lipid changes.

  2013cites this paper
• Estatinas en adultos mayores, una población creciente

  2013cites this paper
• Therapeutic Class Overview HMG CoA Reductase Inhibitors

  2012cites this paper
• Prognostic value of cardiovascular disease status: the Leiden 85-plus study

  2012cites this paper
• The Statin Response Gene: KIF6

  2011cites this paper
• Tratamiento de la dislipemia en grupos especiales: ancianos y embarazadas

  2011cites this paper
• Ideal lipid profile and genes for an extended life span

  2011cites this paper
• The Year in NonST-Segment Elevation Acute Coronary Syndrome

  2011cites this paper
• Dyslipidemias in the older subject: features,significance and treatment dilemmas

  2011cites this paper
• Impact of Cost-sharing on Utilization of Medications for Secondary Prevention of Cardiovascular Morbidity and Mortality in Medicare Beneficiaries

  2011cites this paper
• Age differences in the adherence to treatment guidelines and outcome in patients with ST-elevation myocardial infarction.

  2011cites this paper
• Non-cardiac comorbidities in the very elderly with acute myocardial infarction: prevalence and influence on management and in-hospital mortality.

  2011cites this paper
• Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.

  2011cites this paper
• Acute coronary syndromes in high risk groups: patients with diabetes, the elderly, and women

  2010cites this paper
• Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.

  2010cites this paper
• Use of Statin Therapy to Reduce Cardiovascular Risk in Older Patients

  2010cites this paper
• Prevalence and Coexistence of Cardiovascular Comorbidities among the US Dyslipidemic Population Aged ≥ 65 Years by Lipid-Lowering Medication Use Status

  2010cites this paper
• KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study

  2010cites this paper
• Management of Hyperlipidemia in Older Adults

  2009cites this paper
• Consensus d'experts de la Société Française de Gériatrie et Gérontologie (SFGG) et de la Société Française de Cardiologie (SFC) sur la prise en charge de la maladie coronaire chez le sujet âgé

  2009cites this paper
• Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes: Results From PROVE IT–TIMI 22

  2009cites this paper
• The year in non-ST-segment elevation acute coronary syndrome.

  2009cites this paper
• CHAPTER 38 – Special Patient Populations: Women and Elderly

  2009cites this paper
• Primary and secondary prevention of cardiovascular disease in older adults: a status report.

  2009cites this paper
• Lipid management in the geriatric patient.

  2009cites this paper
• Consensus of the French Society of Gerontology and Geriatrics and the French Society of Cardiology for the management of coronary artery disease in older adults.

  2009cites this paper
• Atorvastatin and cardiovascular risk in the elderly – patient considerations

  2008influential citation
• Secondary Prevention of Coronary Heart Disease in Elderly Patients Following Myocardial Infarction

  2008cites this paper
• [Cardiovascular prevention in the over-80 age group is beneficial].

  2008cites this paper
• Efficacy and safety of intensive statin therapy in the elderly.

  2008cites this paper
• The current role of statins in acute coronary syndrome

  2008cites this paper
• Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

  2008cites this paper
• Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin

  2008cites this paper
• Ischemic Heart Disease & Chronic Heart Failure in the Elderly

  2008cites this paper
• Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).

  2008cites this paper
• Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin.

  2008cites this paper
• Acute Coronary Syndromes in the Elderly

  2007cites this paper
• Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

  2007cites this paper
• Lipid management after acute coronary syndrome

  2007cites this paper
• Einsatz von Statinen bei älteren Menschen

  2007cites this paper
• Rosuvastatin in Elderly Patients

  2007cites this paper
• The clinical and cost-effectiveness of intensive versus standard lipid lowering with statins in the prevention of cardiovascular events amongst patients with acute coronary syndromes: a systematic review

  2007cites this paper
• Infarction : A Scientific Statement for Healthcare Professionals From the Acute Coronary Care in the Elderly , Part II : ST-Segment – Elevation Myocardial

  2007cites this paper
• Acute Coronary Care in the Elderly, Part II: ST-Segment–Elevation Myocardial Infarction A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology

  2007cites this paper
• The year in non-ST-segment elevation acute coronary syndrome.

  2007cites this paper
• Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.

  2007cites this paper
• The year in non-ST-segment elevation acute coronary syndrome.

  2005cites this paper
• Aha Scientific Statement on Behalf of the American Heart Association Committees on Older Populations and Exercise Cardiac Rehabilitation and Prevention of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, and Council on Lifestyle and Cardiometabolic Health. Secondary

  year unknowncites this paper